View Official FDA Web Site

Objectives:

• Increase awareness of Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals as they apply to Medical Gas Industry
• Ensure Medical Gas Industry takes appropriate action to establish effective controls, thus preventing regulatory problems when inspections occur
• Provide working knowledge to FDA investigators to integrate in day-to-day inspections
• Provide the same regulatory message, at the same time, to FDA and state regulators, and medical gas industry

Target Audience:

• Medical Gas Industry
• State regulators of medical gas industry
• FDA regulators of medical gas industry: investigators, supervisors, compliance officers